Syringe Driver Survey Database migration to MedicinesComplete - January 2023

Syringe Driver Survey Database has moved to MedicinesComplete and is no longer available on palliativedrugs.com.

It has been renamed to PCF’s Syringe Driver Database and is now accessed through Drug Compatibility Checker.

Drug Compatibility Checker, through MedicinesComplete is a new tool providing essential compatibility knowledge to support the administration of injectable drugs combining published data and clinical practice reports.

Find out more about Drug Compatibility Checker:https://about.medicinescomplete.com/publication/drug-compatibility-checker/

If you have a subscription to Palliative Care Formulary through MedicinesComplete, you will have access to PCF’s Syringe Driver Database through Drug Compatibility Checker, at no charge through 2023. 

To contribute to PCF’s Syringe Driver Database please continue to submit a clinical practice report using palliativedrugs.com here: https://www.palliativedrugs.com/syringe-driver-database.html

To learn more about a subscription to the Palliative Care Formulary through MedicinesComplete, please contact us here: https://info.medicinescomplete.com/sales

If you have any questions regarding access to PCF’s Syringe Driver Database or would like to renew your subscription to Palliative Care Formulary, please contact pharmpress-support@rpharms.com.

---

Legislation changes for controlled drugs

15th April 2015

Several legislation changes to the Misuse of Drugs Regulations 2001 have been approved by Parliament for England, Scotland and Wales, resulting in changes in practice on 1st June 2015 and 30th November 2015. Those most relevant to palliative care include:

1st June 2015

• temazepam prescriptions will now be required to meet full prescription requirements for Schedule 2 and 3 CDs
• electronic prescribing of Schedule 2 and 3 CDs will be permitted where the Electronic Prescribing System (EPS) is used
• physiotherapist independent prescribers will be able to prescribe the following CDs for the treatment of organic disease or injury:
  • PO diazepam, dihydrocodeine, lorazepam, morphine, oxycodone, temazepam
  • TD fentanyl
  • morphine by injection
• chiropodist/podiatrist independent prescribers will be able to prescribe the following CDs for the treatment of organic disease or injury:
  • PO diazepam, dihydrocodeine, lorazepam, temazepam.

30th November 2015

• ketamine will become a Schedule 2 CD (with exemptions for specific health professionals under Patient Group Directions)
• Standardised requisition forms for Schedule 1, 2 and 3 CDs will become mandatory. Hospices and prisons will be exempt.

Other changes involve the emergency supply of phenobarbital, authority for NHS Ambulance Trusts to possess and supply CDs, authority to supply CDs in prisons, midwife supply orders, paramedic and operating department practitioner stock requisition.

click here to view